ConjuChem Biotechnologies Inc. (TSX:CJB) today announced that it has filed a final short form prospectus with the securities regulatory authorities in each of the provinces of Canada further to the announcement of the filing of a preliminary short form prospectus on November 8, 2006. The prospectus qualifies a public offering of (i) 57,690,000 units at a price of $0.65 per unit on a firm underwritten basis and (ii) a maximum of 127,310,000 additional units on a best efforts basis on the same terms. Each unit consists of one common share of ConjuChem and one half of a common share purchase warrant. Each whole warrant will entitle its holder to purchase one common share for a period of 3 years from the closing of the offering at a purchase price of $1.00 per share. The offering is expected to close on or about November 28, 2006.
